Healthcare provider profile · identity verified

Lance B Joseph

Allopathic & Osteopathic Physicians|Family Medicine · ALTOONA, PA · NPI 1083051361

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Lance B Joseph received $136.40 in general payments during 2025 across 5 reported records.

Lilly USA, LLC accounted for 49.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Farxiga by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 331 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 143 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 221 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$136.40

5 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$67.87	49.8%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$19.04	14.0%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$18.98	13.9%	1	2025
Tonix Medicines, Inc.	Unresolved — no canonical attribution shown	$16.35	12.0%	1	2025
Corcept Therapeutics	Unresolved — no canonical attribution shown	$14.16	10.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$136.40	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$67.87	1	2025
Source payment records 2025-10-29 · Lilly USA, LLC · $67.87 · Open Payments source
AIRSUPRA Normalized: airsupra	Drug	AstraZeneca Pharmaceuticals LP	$19.04	1	2025
Source payment records 2025-12-16 · AstraZeneca Pharmaceuticals LP · $19.04 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.98	1	2025
Source payment records 2025-11-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $18.98 · Open Payments source
TONMYA Normalized: tonmya	Drug	Tonix Medicines, Inc.	$16.35	1	2025
Source payment records 2025-12-23 · Tonix Medicines, Inc. · $16.35 · Open Payments source
Korlym Normalized: korlym	Drug	Corcept Therapeutics	$14.16	1	2025
Source payment records 2025-12-09 · Corcept Therapeutics · $14.16 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	23	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	331	71
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	143	27
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	221	30

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1078	276
Lisinopril	Lisinopril	866	222
Pantoprazole Sodium	Pantoprazole Sodium	701	184
Amlodipine Besylate	Amlodipine Besylate	696	179
Metformin Hcl	Metformin Hcl	597	149
Levothyroxine Sodium	Levothyroxine Sodium	592	132
Losartan Potassium	Losartan Potassium	582	146
Gabapentin	Gabapentin	555	133
Lorazepam	Lorazepam	459	79
Omeprazole	Omeprazole	403	111
Hydrochlorothiazide	Hydrochlorothiazide	396	105
Rosuvastatin Calcium	Rosuvastatin Calcium	394	117
Potassium Chloride	Potassium Chloride	385	99
Alprazolam	Alprazolam	377	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	350	57
Jardiance	Empagliflozin	331	71
Tamsulosin Hcl	Tamsulosin Hcl	321	82
Simvastatin	Simvastatin	314	84
Eliquis	Apixaban	313	54
Famotidine	Famotidine	300	93
Metoprolol Succinate	Metoprolol Succinate	287	78
Oxycodone Hcl	Oxycodone Hcl	286	39
Baclofen	Baclofen	283	52
Furosemide	Furosemide	256	72
Clonazepam	Clonazepam	248	37
Montelukast Sodium	Montelukast Sodium	245	57
Bupropion Xl	Bupropion Hcl	243	66
Escitalopram Oxalate	Escitalopram Oxalate	238	58
Duloxetine Hcl	Duloxetine Hcl	235	58
Allopurinol	Allopurinol	224	57
Trulicity	Dulaglutide	221	30
Albuterol Sulfate Hfa	Albuterol Sulfate	219	55
Ozempic	Semaglutide	208	39
Zolpidem Tartrate	Zolpidem Tartrate	205	35
Clopidogrel	Clopidogrel Bisulfate	203	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	199	49
Carvedilol	Carvedilol	193	47
Tramadol Hcl	Tramadol Hcl	192	32
Sertraline Hcl	Sertraline Hcl	184	50
Meloxicam	Meloxicam	177	38
Metoprolol Tartrate	Metoprolol Tartrate	175	50
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	159	25
Metformin Hcl Er	Metformin Hcl	158	41
Ropinirole Hcl	Ropinirole Hcl	152	31
Tizanidine Hcl	Tizanidine Hcl	152	43
Mirtazapine	Mirtazapine	145	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	144	31
Mounjaro	Tirzepatide	143	27
Hydroxyzine Hcl	Hydroxyzine Hcl	141	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	134	37
Citalopram Hbr	Citalopram Hydrobromide	130	41
Finasteride	Finasteride	126	30
Topiramate	Topiramate	122	26
Temazepam	Temazepam	119	21
Buspirone Hcl	Buspirone Hcl	118	35
Atenolol	Atenolol	111	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	108	20
Methenamine Hippurate	Methenamine Hippurate	106	21
Fluoxetine Hcl	Fluoxetine Hcl	104	23
Warfarin Sodium	Warfarin Sodium	102	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	101	21
Fluticasone Propionate	Fluticasone Propionate	101	32
Ondansetron Odt	Ondansetron	101	34
Glipizide Er	Glipizide	100	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	100	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	28
Glimepiride	Glimepiride	99	24
Synthroid	Levothyroxine Sodium	98	26
Triamcinolone Acetonide	Triamcinolone Acetonide	96	36
Ondansetron Hcl	Ondansetron Hcl	91	22
Pravastatin Sodium	Pravastatin Sodium	89	24
Methylprednisolone	Methylprednisolone	88	77
Spironolactone	Spironolactone	86	20
Ezetimibe	Ezetimibe	85	21
Alfuzosin Hcl Er	Alfuzosin Hcl	84	20
Trazodone Hcl	Trazodone Hcl	84	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	81	12
Bupropion Hcl Sr	Bupropion Hcl	79	16
Prednisone	Prednisone	73	33
Venlafaxine Hcl Er	Venlafaxine Hcl	72	18
Amitriptyline Hcl	Amitriptyline Hcl	69	suppressed
Fentanyl	Fentanyl	69	11
Ibuprofen	Ibuprofen	69	18
Esomeprazole Magnesium	Esomeprazole Magnesium	67	19
Dicyclomine Hcl	Dicyclomine Hcl	64	15
Celecoxib	Celecoxib	62	14
Alendronate Sodium	Alendronate Sodium	60	16
Lactulose	Lactulose	58	13
Xarelto	Rivaroxaban	57	suppressed
Donepezil Hcl	Donepezil Hcl	53	12
Estradiol	Estradiol	52	14
Prochlorperazine Maleate	Prochlorperazine Maleate	52	21
Propranolol Hcl	Propranolol Hcl	52	14
Solifenacin Succinate	Solifenacin Succinate	51	11
Diazepam	Diazepam	50	suppressed
Nystatin	Nystatin	49	26
Primidone	Primidone	49	suppressed
Valacyclovir	Valacyclovir Hcl	49	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	48	11
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	45	suppressed
Methocarbamol	Methocarbamol	45	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	28
Nortriptyline Hcl	Nortriptyline Hcl	44	11
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Ventolin Hfa	Albuterol Sulfate	43	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	42	suppressed
Premarin	Estrogens, Conjugated	41	23
Naproxen	Naproxen	40	13
Clonidine Hcl	Clonidine Hcl	39	suppressed
Memantine Hcl	Memantine Hcl	38	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Azelastine Hcl	Azelastine Hcl	37	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	suppressed
Terazosin Hcl	Terazosin Hcl	37	suppressed
Azithromycin	Azithromycin	35	30
Linzess	Linaclotide	35	suppressed
Meclizine Hcl	Meclizine Hcl	35	22
Olanzapine	Olanzapine	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Bumetanide	Bumetanide	34	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	14
Carbamazepine Er	Carbamazepine	33	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Myrbetriq	Mirabegron	33	suppressed
Rizatriptan	Rizatriptan Benzoate	33	suppressed
Carisoprodol	Carisoprodol	32	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	32	suppressed
Labetalol Hcl	Labetalol Hcl	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Levofloxacin	Levofloxacin	28	26
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	11
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Amoxicillin	Amoxicillin	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Morphine Sulfate	Morphine Sulfate	25	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	24	13
Pregabalin	Pregabalin	24	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Cholestyramine	Cholestyramine (With Sugar)	23	suppressed
Dexamethasone	Dexamethasone	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Fluconazole	Fluconazole	23	18
Zonisamide	Zonisamide	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	17
Midodrine Hcl	Midodrine Hcl	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Cefdinir	Cefdinir	21	18
Cephalexin	Cephalexin	21	20
Divalproex Sodium	Divalproex Sodium	21	suppressed
Ibu	Ibuprofen	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Colchicine	Colchicine	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Glipizide	Glipizide	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Xanax	Alprazolam	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Dilt-Xr	Diltiazem Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Victoza 3-Pak	Liraglutide	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Potassium Citrate Er	Potassium Citrate	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	11
Irbesartan	Irbesartan	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Torsemide	Torsemide	16	suppressed
Valsartan	Valsartan	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Cholestyramine Light	Cholestyramine	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Piroxicam	Piroxicam	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	14
Constulose	Lactulose	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Entacapone	Entacapone	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Striverdi Respimat	Olodaterol Hcl	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$136.40 · 5 records	Lilly USA, LLC	AIRSUPRA, CAPLYTA, Korlym, TONMYA, ZEPBOUND	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error